Caricamento...

A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms

Patients with myeloproliferative neoplasms (MPNs), polycythemia vera, essential thrombocythemia, and primary myelofibrosis, have an increased risk of thrombosis. Risk of recurrent thrombosis can be reduced with antithrombotic therapy and/or cytoreduction, but the optimal long-term management in pati...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Blood Adv
Autori principali: Hamulyák, Eva N., Daams, Joost G., Leebeek, Frank W. G., Biemond, Bart J., te Boekhorst, Peter A. W., Middeldorp, Saskia, Lauw, Mandy N.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2021
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7805324/
https://ncbi.nlm.nih.gov/pubmed/33570633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003628
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !